ArticleCureus2026
Subjective and Objective Evaluation of a Novel Nasal Tip Elevating Strip for Nasal Obstruction: A Pilot Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Chronic nasal obstruction represents a significant clinical challenge in rhinology, frequently leading to a reduction in respiratory function and a measurable impact on patient-reported quality of life. While external nasal dilators are frequently utilised as a non-invasive treatment, most existing devices focus solely on lateral nasal valve stabilisation. A novel biomechanical approach involving nasal tip elevation may offer additional symptomatic relief, particularly as a temporary measure for patients awaiting definitive surgical correction. The objective of this pilot study was to evaluate the clinical impact of a novel biomechanical approach, based on nasal tip elevation, on both patient-reported symptoms and objective inspiratory airflow. Materials and methods A prospective study was conducted between December 2025 and June 2026 on 29 Caucasian adults (mean age 42.86 ± 11.09 years) with severe nasal septal deviation and inferior turbinate hypertrophy. Objective patency was assessed using peak nasal inspiratory flow (PNIF). Subjective outcomes were evaluated via a visual analog scale (VAS) for breathing ease at day one, and nasal obstruction symptom evaluation (NOSE) and Epworth sleepiness scale (ESS) questionnaires after seven days of treatment. Results NOSE scores diminished significantly after one week (from 12.41 ± 3.88 to 10.45 ± 3.52; p < 0.05). VAS scores demonstrated an improvement trend that did not reach statistical significance (p = 0.07). No significant changes were registered in PNIF or ESS values between baseline and the end of the treatment period. No major complications occurred; only one patient (3.4%) noted minor skin redness at the application site, with no study dropouts. Conclusions The novel nasal tip-elevating strip provides significant symptomatic relief in patients with chronic nasal obstruction. It represents an effective non-invasive tool for symptomatic management and a reliable bridge therapy for individuals awaiting definitive surgical correction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.